tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
InMed Completes Key Pharmacokinetic Studies for Alzheimer’s Candidate INM-901
PremiumCompany AnnouncementsInMed Completes Key Pharmacokinetic Studies for Alzheimer’s Candidate INM-901
3M ago
InMed Pharmaceuticals Reports Q3 2025 Financial Results
Premium
Company Announcements
InMed Pharmaceuticals Reports Q3 2025 Financial Results
3M ago
InMed Pharmaceuticals Advances Alzheimer’s Program Amidst Strong Fiscal Start
Premium
Company Announcements
InMed Pharmaceuticals Advances Alzheimer’s Program Amidst Strong Fiscal Start
3M ago
InMed Pharmaceuticals Advances Alzheimer’s Program with Promising Results
PremiumCompany AnnouncementsInMed Pharmaceuticals Advances Alzheimer’s Program with Promising Results
5M ago
InMed Pharmaceuticals reports FY25 EPS ($8.36) vs ($20.14) last year
Premium
The Fly
InMed Pharmaceuticals reports FY25 EPS ($8.36) vs ($20.14) last year
5M ago
InMed Pharmaceuticals to Showcase Pipeline Progress at Global Investment Conference
Premium
Company Announcements
InMed Pharmaceuticals to Showcase Pipeline Progress at Global Investment Conference
5M ago
InMed Pharmaceuticals Secures $5 Million in Private Placement to Advance Drug Development
PremiumCompany AnnouncementsInMed Pharmaceuticals Secures $5 Million in Private Placement to Advance Drug Development
8M ago
InMed Pharmaceuticals announces $5M private placement
Premium
The Fly
InMed Pharmaceuticals announces $5M private placement
8M ago
Morning Movers: TD Synnex slips following second quarter results
Premium
The Fly
Morning Movers: TD Synnex slips following second quarter results
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100